Cargando…

An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa Virus

Nigeria experiences annual outbreaks of Lassa fever (LF) with high case numbers. At least three clades of Lassa virus (LASV) have been documented in Nigeria, though recent outbreaks are most often associated with clade II or clade III viruses. Using a recently isolated clade III LASV from a case of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deschambault, Yvon, Soule, Geoff, Klassen, Levi, Sloan, Angela, Audet, Jonathan, Azaransky, Kim, Musa, Abdulmajid S., Ahmad, Adama, Akinpelu, Afolabi M., Mba, Nwando, Stein, Derek R., Ranson, Marc, Almiski, Muhamad, Tierney, Kevin, Fischer, Gabor, Chan, Mable, Safronetz, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052409/ https://www.ncbi.nlm.nih.gov/pubmed/36992478 http://dx.doi.org/10.3390/v15030769

Ejemplares similares

Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates
por: Stein, Derek R., et al.
Publicado: (2021)

Experimental Infection of North American Deer Mice with Clade I and II Monkeypox Virus Isolates
por: Deschambault, Yvon, et al.
Publicado: (2023)

Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018
por: Ashcroft, Jonathan W., et al.
Publicado: (2022)

A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs
por: Stein, Derek R., et al.
Publicado: (2019)

Detection of Lassa Virus, Mali
por: Safronetz, David, et al.
Publicado: (2010)

Current research for a vaccine against Lassa hemorrhagic fever virus
por: Warner, Bryce M, et al.
Publicado: (2018)

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
por: Lingas, Guillaume, et al.
Publicado: (2021)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Learning in the Lassa Belt
por: Sandige, Heidi
Publicado: (2018)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation
por: Maruyama, Junki, et al.
Publicado: (2019)

On the Front Lines of Lassa Fever
por: Bausch, Daniel G., et al.
Publicado: (2004)

New Hosts of The Lassa Virus
por: Olayemi, Ayodeji, et al.
Publicado: (2016)

Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020)

Phylogeography of Lassa Virus in Nigeria
por: Ehichioya, Deborah U., et al.
Publicado: (2019)

Lassa Virus Treatment Options
por: Hansen, Frederick, et al.
Publicado: (2021)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria
por: Olayinka, Adebola T., et al.
Publicado: (2022)

Experimental Infection of Peromyscus Species Rodents with Sin Nombre Virus
por: Quizon, Kaye, et al.
Publicado: (2022)

Epidemiological trends of Lassa fever in Nigeria, 2018–2021
por: Dalhat, Mahmood M., et al.
Publicado: (2022)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
por: Yadouleton, Anges, et al.
Publicado: (2020)

Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development
por: Ibukun, Francis Ifedayo
Publicado: (2020)

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever
por: Lan, Shuiyun, et al.
Publicado: (2020)

Pichinde Virus Infection of Outbred Hartley Guinea Pigs as a Surrogate Animal Model for Human Lassa Fever: Histopathological and Immunohistochemical Analyses
por: Shieh, Wun-Ju, et al.
Publicado: (2020)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Etymologia: Lassa [lah sə] virus
Publicado: (2010)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)

Immune Responses and Lassa Virus Infection
por: Russier, Marion, et al.
Publicado: (2012)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Lassa fever and global health security
por: The Lancet Infectious Diseases
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e0rl7br110208m1b9f9jihato8